Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18–55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial

Keith J. Chappell(Australian Research Council), Daniel Watterson(The University of Queensland), Marianne Gillard(The University of Queensland), Jillian Bennet, Julia Lackenby(The University of Queensland), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Trent P. Munro(The University of Queensland), Kym Hoger(The University of Queensland), Vivian Kienzle(The University of Queensland), Nicolas Tardiota(The University of Queensland), Martina L. Jones(The University of Queensland), Benjamin Liang(The University of Queensland), Charani Ranasinghe(Australian National University), Jake S. O’Donnell(The University of Queensland), Zheyi Li(Australian National University), Benjamin Hughes(The University of Queensland), Rhiannon L. Dalrymple(The University of Queensland), Patrick C. Reading(Peter Doherty Institute), Noushin Jaberolansar(The University of Queensland), Christina L Henderson(The University of Queensland), Paul R. Young(Kent State University), Kanta Subbarao(Peter Doherty Institute), James Barnes(Peter Doherty Institute), Francesca L. Mordant(The University of Melbourne), Naphak Modhiran(The University of Queensland), Karen Hughes(Bangor University), Varsha Kommajosyula(The University of Queensland), Justin B. Goh(The University of Queensland)
The Journal of Infectious Diseases
November 10, 2025
Cited by 1


Related Papers